1.6500
22-十一月-24 15:44:58
15 分钟延时
股票
+0.0500
+3.12%
今日范围
1.5800 - 1.6800
ISIN
N/A
来源
NASDAQ
Chemomab to Host Virtual Key Opinion Leader Webinar on Primary Sclerosing Cholangitis on April 10, 2024
02 4月 2024 06:00:00 条件 Nasdaq GlobeNewswire
Chemomab Awarded New European Patent for CM-101, Its First-in Class Monoclonal Antibody in Phase 2 Clinical Development for Primary Sclerosing Cholangitis
25 3月 2024 06:06:46 条件 Nasdaq GlobeNewswire